Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial
about
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH)Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis.A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritisTrajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort.THE EARLY BIRD CATCHES THE WORM: EARLY COST-EFFECTIVENESS ANALYSIS OF NEW MEDICAL TESTS.Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.Brief Report: to squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis.Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method.
P2860
Q30812918-8F4D2760-496A-4990-AF30-35406B1C966DQ35138342-B5FE677A-29A5-44BB-A2B3-BB463D767A0CQ35757314-8E81722D-44F1-4ABD-AA8D-19A1A43401C3Q36633458-E8FC008E-F3BC-4BF5-A82F-BD88FA206F8EQ36994587-C9A9CDB9-F7D6-4512-8CD7-B71733D4A9C6Q37065251-8EC6D7C9-E93A-4863-A3A2-C405A9807F9DQ40839705-40809802-67A6-49BB-A6A9-828FD360F66FQ44050282-743AF7E9-7881-4CA3-B6F8-8EE816308B21Q44621683-67BDDB4B-EC97-4D77-B838-C2E1C993E550Q45917390-0BFE8E58-E7FF-4AA1-89C3-0F3A1FA57638Q46585284-BC159FC4-604A-47D8-B75F-132038761E19
P2860
Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Use of risk stratification to ...... d multicenter controlled trial
@ast
Use of risk stratification to ...... d multicenter controlled trial
@en
type
label
Use of risk stratification to ...... d multicenter controlled trial
@ast
Use of risk stratification to ...... d multicenter controlled trial
@en
prefLabel
Use of risk stratification to ...... d multicenter controlled trial
@ast
Use of risk stratification to ...... d multicenter controlled trial
@en
P2093
P2860
P356
P1476
Use of risk stratification to ...... d multicenter controlled trial
@en
P2093
Angelique E A M Weel
Derkjen van Zeben
Johanna M W Hazes
Jolanda J Luime
Margriet A M Huisman
Susanne J J Claessen
P2860
P2888
P356
10.1186/1471-2474-10-71
P577
2009-06-18T00:00:00Z
P5875
P6179
1004481270